tnx-102
Generic: levosimendan·Code: TNX-102
tnx-102: developed by 1 company. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | Phase 3 |
Get deeper analysis on tnx-102
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis